Table 1.
Rate of production of lung liquid (ml (kg body wt)−1 h−1) | Sig. of reductions during treatment | Sig. of reductions aafter treatment | |||||||
---|---|---|---|---|---|---|---|---|---|
Dopamine m | Na+ channel blockers m | n | Hour before treatment | Hour during treatment | Hour after treatment | ANOVA | Regression analysis | ANOVA | Regression analysis |
10−4 | 0 | 6 | 1.27 ± 0.09 | −0.27 ± 0.15 | 0.28 ± 0.32 | P < 0.0005 | P < 0.0005 | P < 0.005 | P < 0.0005 |
Untreated controls | 6 | 1.17 ± 0.23 | 1.14 ± 0.30 | 1.02 ± 0.14 | n.s. | n.s. | n.s. | n.s. | |
10−4 | 10−6 amiloride | 12 | 1.17 ± 0.09 | −0.24 ± 0.07 | 0.27 ± 0.12 | P < 0.0005 | P < 0.0005 | P < 0.005 | P < 0.0005 |
0 | 10−6 amiloride | 6 | 1.48 ± 0.26 | 1.23 ± 0.16 | 1.18 ± 0.21 | n.s. | n.s. | n.s. | n.s. |
10−4 | 10−5 amiloride | 3 | 1.14 ± 0.24 | −0.39 ± 0.09 | −0.39 ± 0.18 | P < 0.025 | P < 0.0005 | P < 0.025 | P < 0.0005 |
0 | 10−4 amiloride | 3 | 0.97 ± 0.17 | 0.98 ± 0.12 | 0.70 ± 0.17 | n.s. | n.s. | n.s. | n.s. |
10−4 | 10−4 amiloride | 3 | 0.90 ± 0.21 | −0.50 ± 0.11 | −0.09 ± 0.03 | P < 0.005 | P < 0.0005 | P < 0.01 | P < 0.0005 |
0 | 10−4 amiloride | 3 | 1.40 ± 0.12 | 1.44 ± 0.46 | 1.18 ± 0.36 | n. s. | n.s. | n.s. | n.s. |
10−4 | 10−5 benzamil | 6 | 1.17 ± 0.15 | −0.22 ± 0.16 | −0.08 ± 0.14 | P < 0.0005 | P < 0.0005 | P < 0.0005 | P < 0.0005 |
0 | 10−5 benzamil | 6 | 1.06 ± 0.22 | 1.03 ± 0.11 | 1.07 ± 0.15 | n.s. | n.s. | n.s. | n.s. |
All values are means ±s.e.m. Sig., significance.